John Vissing

John Vissing

Clinical Professor

Member of:

  • Neurology


  1. 2020
  2. Published

    ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

    Vissing, J., Jacob, S., Fujita, K. P., O’Brien, F., Howard, J. F., The REGAIN Study Group, Mazia, C. G., Wilken, M., Barroso, F., Saba, J., Rugiero, M., Bettini, M., Chaves, M., Vidal, G., Garcia, A. D., De Bleecker, J., Van den Abeele, G., de Koning, K., De Mey, K., Mercelis, R. & 36 others, Mahieu, D., Wagemaekers, L., Van Damme, P., Depreitere, A., Schotte, C., Smetcoren, C., Stevens, O., Van Daele, S., Vandenbussche, N., Vanhee, A., Verjans, S., Vynckier, J., D’Hont, A., Tilkin, P., Alves de Siqueira Carvalho, A., Dias Brockhausen, I., Feder, D., Ambrosio, D., César, P., Melo, A. P., Martins Ribeiro, R., Rocha, R., Rosa, B. B., Veiga, T., da Silva, L. A., Andersen, H., Harbo, T., Vinge, L., Krogh, S., Mogensen, A., Vissing, John, Højgaard, J., Witting, N., Autzen, A. M. O., Pedersen, J. & Weiss, M., 2020, In: Journal of Neurology. 267, p. 1991-2001

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 Next

ID: 915367